Navigation Links
Arthroscopic Treatment of Tennis Elbow is Successful

According to new research released today at the annual Meeting of the American Orthopaedic Society for Sports Medicine at the Telus Convention Center,arthroscopic treatment of tennis elbow has shown to be successful at long-term follow-up.

This is the first longitudinal study of arthroscopic treatment of tennis elbow, says lead investigator Champ L. Baker, III, M.D., an orthopaedic resident at the University of Pittsburgh.

The initial success from our original short-term study was maintained long term. I am happy to say that arthroscopic release is a good treatment option for lingering tennis elbow. The patients were enrolled through the Hughston Clinic in Columbus, Ga., where Dr. Bakers father and the senior study investigator, Champ L. Baker, Jr., M.D., practices orthopaedic sports medicine surgery.

Tennis elbow, a potentially debilitating condition, is common and can be successfully managed without surgery in almost 90% of cases. When it cannot be controlled by nonoperative measures, including rest, the arthroscopic technique used in this study is one of the many different surgical options that have good outcomes.

Investigators studied the long-term (130 month) pain and functional scores of 30 patients who underwent arthroscopic release for tennis elbow. The short-term results from this patient group were published in The Journal of Shoulder and Elbow Surgery in 2000 (9:475-82).

The researchers found that arthroscopic treatment provided very good results in terms of long-term pain relief and functional restoration. There were no repeat surgeries or injections. Satisfaction rates were also high, with 93% of the patients stating that they would have the surgery again if needed.

Athletes are not the only population vulnerable to tennis elbow. People in their 40s and 50s who do repetitive activities are often afflicted. Such activities can range from repetitively lifting boxes to repeti
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
(Date:12/4/2009)...irstCall/ -- Care Investment Trust Inc. (NYSE: ...hat its Board of Directors has declared a dividend... is payable on December 22, 2009 to common shareho...out Care Investment Trust ,, Care Investment T...company investing in healthcare-related real estat...
(Date:12/4/2009)...swire/ -- Medithrive, Inc. has won the Patient,s C...ay Area by popular vote conducted by the online we...hs in operation, the SF Bay community has selected...ng medicinal marijuana. ,, The rapid rise and...dispensary which caters to the consumer, provides ...
(Date:12/4/2009)...-USNewswire/ -- The American Association of Homes ...nate for ensuring that the Community Living and S...e final health reform legislation . The CLASS prov...rs, people with disabilities and their caregivers....eform bill that will make it affordable to care fo...
(Date:12/4/2009)...Newswire/ -- The large, two-day free health clinic...nics (NAFC) in Kansas City on Wednesday and Thursd...o is uninsured and has not seen a doctor recently....e preventive primary care. ,, "Many people who...nts this fall in Houston, New Orleans and Little R...
(Date:12/4/2009)...Newswire/ -- Pamela Bowen, Chief Information Offic...ist for the "Chief Innovation Officer" Appy Award ...r of cloud computing. Appy Award recipients are no...rce CRM or the Force.com platform in bringing new ...ng, partner, service, support or IT organizations....
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
..., The Association for Gerontology in Higher Educ...ntological Society of America , will hold its 35t...ence February 26March 1, 2009, at the Crowne Pla... about gerontological and geriatric education and ...
..., CARLSBAD, Calif., Jan. 30 Beautiful skin wi...you may actually save money on skin care,this year...tress level and,cleaning out your cabinets. , ...skin. With the ten thrifty tips, this host of "Ski...
..., RED BANK, New Jersey, BRUSSELS and MELBOURNE...obal corporate,website. With over a century of exp...otective solutions is now rethinking its presence ... The site includes corporate information with ...
..., Three New Studies Initiated in Other Oncology Se...0 GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN)...ense Application (BLA) to the U.S. Food and Drug A...erapies. If approved, ofatumumab would be the firs...
..., SAN DIEGO and LISLE, Ill., Jan. 30 SpineMar...that partners with hospitals and,physicians to dev... a,partnership with Healthplace America to deliver...Surgery Benefit(TM). As a result,of their affilia...
..., MIAMI, Jan. 30 Physicians Healthcare Managemen...developer of health maintenance organizations (HMO...hyshield Insurance Exchange, a licensed medical ma...ongress and a new administration in Washington. H...
Other Medicine News:Health News:Teaching about financial crisis among Gerontology Meeting's highlights 2Health News:Ten Thrifty Tips for Radiant Skin 2Health News:Ten Thrifty Tips for Radiant Skin 3Health News:Ansell Limited Launching a New Global Website 2Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 2Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 3Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 4Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 5Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 6Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 7Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 8Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 2Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 3Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 4Health News:Phyhealth Provides Update to Shareholders 2Health News:Phyhealth Provides Update to Shareholders 3Health News:Phyhealth Provides Update to Shareholders 4
(Date:12/4/2009)..., , INDIANAPOLIS, Dec. 4 /PRNewswire-...ion (FDA) today approved Zyprexa® (olanzapine... schizophrenia and manic or mixed episodes associa...-17 years old. ,, The updated Zyprexa label st...n the increased potential for weight gain and hype...
(Date:12/4/2009)..., , OMAHA, Neb., Dec. 4 Am...editation by the Accreditation Commission for Heal...ices. For nearly 15 years, Amber Pharmacy has prov...ices to meet the unique needs of specialized condi...ers of services to transplant programs. They work ...
(Date:12/4/2009)..., , STREAMWOOD, Ill., Dec. 4 /PRNewswire/...f CT, MRI and PET/CT systems and service programs ... to announce it has received The Joint Commission,...onally-recognized, prestigious gold seal of approv...Imaging accreditation is system-wide for its mobil...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Gut worms may protect against house dust mite allergy 58400 1Gut worms may protect against house dust mite allergy 58400 2Gut worms may protect against house dust mite allergy 58400 3Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 1Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 2Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 3Canker disease in eucalyptus in the Basque Country 10128 1Canker disease in eucalyptus in the Basque Country 10128 2Canker disease in eucalyptus in the Basque Country 10128 3Canker disease in eucalyptus in the Basque Country 10128 4
... ANTIPOLIS, France, Nov. 7 NicOx S.A.,(Eurolist: ...xploratory,pharmacodynamic study for naproxcinod u...ere presented yesterday at the American Heart,Asso...ida. Naproxcinod is,the first compound in the COX-...ammatory agents and is in clinical development for...
..., Nov. 7 Vital Therapies, Inc. (VTI), announced,t...) (Extracorporeal Liver,Assist Device) System were...e Study of Liver Diseases (AASLD) Annual Meeting, ...Abstract (#91), "Interim results of Randomized Con...Liver Disease," was presented in a parallel s...
Other Medicine Technology:NicOx' Naproxcinod ABPM Data Presented at American Heart Association 2NicOx' Naproxcinod ABPM Data Presented at American Heart Association 3NicOx' Naproxcinod ABPM Data Presented at American Heart Association 4Vital Therapies Announces Presentation of ELAD(R) 'Artificial Liver' Data at American Association for the Study of Liver Diseases 2007 Annual Meeting 2
AGC Revision knee
Advance Stemmed Medial-Pivot Knee
AGC Dual Articular Knee
Scorpio TS Single Axis Revision Knee System
Medicine Products: